Ischemic Heart Disease Clinical Trial
Official title:
Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson
The objective for this pilot study is to develop an optimized, clinically usable myocardial
PET-MR perfusion protocol and to determine which of all data potentially available should be
acquired for a clinical myocardial perfusion examination. Hypothesis: The hypothesis is that
high resolution, high sensitivity DCE MRI could replace the rest PET myocardial perfusion
imaging, significantly decreasing examination time and patient radiation dose while
maintaining the comprehensive reference-quality PET myocardial stress perfusion coverage.
The primary outcome will be comparison of diagnostic accuracy of each combination of imaging
to detect clinically significant coronary artery stenosis (≥70% diameter stenosis).
Simultaneous acquisition PET-MRI is a new technology that has the potential to significantly
impact diagnostic patient care. It combines high signal resolution MRI anatomic imaging and
PET biological measurements, with the added benefit of radiation dose reduction in comparison
to PET-CT. As the incidence of false positive SPECT-MPI studies secondary to attenuation
artifact is relatively high and MRI coverage of the left ventricular myocardium is limited,
it is likely that one of the immediate applications of PET-MRI technology is myocardial
ischemia assessment.
PET has long been considered the noninvasive reference standard for myocardial perfusion.
However, delayed contrast enhanced (DCE) MRI is very sensitive for infarct detection. Indeed,
both PET and MR imaging have the potential to provide comprehensive whole heart ischemia and
infarct detection.
PET-MR technology, with its ability to obtain simultaneous perfusion information via both PET
and MRI, has the potential to obtain multiple, possibly redundant, data sets. On the other
hand, it also has the potential to combine the best of both techniques to provide a highly
robust examination that is both shorter and of lower radiation dose than the standard
myocardial PET perfusion examination. Optimization of a protocol is necessary to develop a
comprehensive protocol without redundancy. Because of its single injection capability,
regadenoson is ideally suited to a protocol that will assess and employ dual-modality
myocardial perfusion data collection.
It is expected that the best candidates for PET-MR myocardial perfusion imaging will likely
be a) patients whose body habitus suggests that their SPECT-MPI examination would be limited
by attenuation artifact -- women with large breasts and patients (usually men) with abdominal
obesity and/or b) patients who may have a smaller region of ischemia that might be missed on
an MRI examinations with limited perfusion coverage.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Active, not recruiting |
NCT04562805 -
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
|
N/A | |
Recruiting |
NCT05292079 -
CAPTURER PMCF Study ( rEPIC04D )
|
||
Recruiting |
NCT05292014 -
ANGIOLITE PMCF Study ( rEPIC04F )
|
||
Recruiting |
NCT05292118 -
Navitian PMCF Study ( rEPIC04C )
|
||
Recruiting |
NCT05292092 -
Essential Pro PMCF Study ( rEPIC04E )
|
||
Completed |
NCT05292105 -
NC Xperience PMCF Study( rEPIC04B)
|
||
Completed |
NCT03076801 -
Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
|
N/A | |
Not yet recruiting |
NCT04153383 -
Milrinone on Cardiac Performance During Off-pump Coronary Artery Bypass Surgery
|
||
Recruiting |
NCT02982434 -
The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation
|
Phase 2 | |
Recruiting |
NCT02729064 -
Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose
|
Phase 1 | |
Completed |
NCT02468401 -
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
|
N/A | |
Completed |
NCT02759406 -
Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study
|
N/A | |
Recruiting |
NCT01681381 -
Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization
|
N/A | |
Completed |
NCT01699802 -
Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa)
|
N/A | |
Completed |
NCT01604213 -
Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01334268 -
RESOLUTE China RCT
|
N/A | |
Completed |
NCT01724567 -
Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training
|
N/A | |
Completed |
NCT02159235 -
Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)
|
N/A |